Cannaray Limited, a leading European medical cannabis company headquartered in London, is thrilled to announce it has signed a definitive agreement to merge with Aqualitas Inc., a Nova Scotia-licenced, medical cannabis cultivator and processor and drug establishment license (DEL) holder with EU GMP, cGMP, GAP & Clean Green® organic certifications. Aqualitas is home to Canada's top grower of the year and has developed an innovative cultivation system using living soil and aquaponic fertilisation
Aqualitas possesses a cultivation system using living soil and aquaponic fertilisation from the nutrient dense waste of 3,000 koi carp fish, which has produced medical cannabis products.
Cellular Goods PLC (LSE:CBX) saw its streamlining programme result in a cost base reduction of 56% for its first half ending February 28, 2023, which helped.
Cellular Goods PLC (LSE:CBX) told investors it has signed a letter of intent for the potential acquisition of Cannaray Brands Ltd & Love CBD Health Ltd,.